Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma.

Authors:
Kim S; Chung H; Kwak JE; Kim YR; Park CH and 6 more

Journal:
J Immunother Cancer

Publication Year: 2024

DOI:
10.1136/jitc-2023-007886

PMCID:
PMC10806558

PMID:
38191242

Journal Information

Full Title: J Immunother Cancer

Abbreviation: J Immunother Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests: JW is the inventor of the huB10G5 antibody with international patents and the remaining authors declare no potential conflicts of interest."

Evidence found in paper:

"Funding: This study was supported by a "Hankookilbo Myung-Ho Seung" Faculty Research Assistance Program of Yonsei University College of Medicine (6-2021-0101), National Research Foundation grant and funded by the Ministry of Science and ICT, Republic of Korea (RS-2023-00208390) and grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI22C1217 and HI22C1826)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025